STRATEGIC PLAN Q2 2019 - MYM · for exceptional genetic development and archiving. At 10,000 sf, Phase 1 is complete and awaiting licensing from Health Canada. The Cannabis Tracking

PRIVILEGED & CONFIDENTIALMYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF

STRATEGIC PLAN Q2 2019

This Business Plan is confidential. Unauthorized reproduction or distribution of it or any of its contents in any form or under any circumstances without prior written consent is prohib-

ited. The Recipient is responsible for returning all copies of the Plan immediately upon request of the Company. The information contained herein is: (i) provided by the principal found-

ers of the business and (ii) publicly available from directories, publications, and websites, as mentioned in the body and the footnotes where possible or appropriate. In some cases,

non-publicly available information was used, including independent research, studies or paid services from individuals and organizations. While the information set forth herein is

deemed by the Company to be accurate, the Company shall not be held liable for the accuracy of or any omissions from this Business Plan or for any other written or oral communica-

tion transmitted to the Recipient and any other party in the course of its evaluation of transactions involving the Company.

The information contained in the plan will require careful scrutiny, verification and due diligence efforts from the Recipients of the plan. Any person or entity seeking to make an

investment in the business should not rely on the information set forth in the plan as complete. In addition, the analyses contained herein do not claim to be appraisals of the assets or

the valuation of any entity. The business makes no guarantees regarding any benefits received from an investment, nor the legal, tax or accounting effects of any transaction; and this

Plan does not constitute an offer to sell, or a solicitation of an offer to buy securities. In furnishing the Business Plan, the Company undertakes no obligation to provide Recipients of

the Business Plan with access to any additional information or to update this Business Plan or to correct any inaccuracies that may be contained herein. There exists substantial

information with respect to the business and its future prospects, and there are a substantial number of risks associated with an investment in the business, which are not set forth in

the plan.

Furthermore, the potential fulfillment of “forward looking statements” contained in the plan are subject to change due to unexpected events, market shifts, or circumstances that

cannot be known at this time. Forward looking statements are based on expectations, estimates and projections at the time the statements were made that involve a number of eco-

nomic, business, and numerous risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in

the plan may be identified through the use of words such as, but not exclusively to: “expects,” “will,” “anticipates,” “estimates,” “believes,” or statements indicating certain actions

“may,” “could,” or “might” occur. Such estimates and projections are subject to significant uncertainties beyond the control of the Company. Although such projections are believed to

be realistic, no representations are made as to their ultimate attainability.

Confidentiality Statement and Legal Disclaimer



MYM Nutraceuticals is focused on constructing high quality cultivation facilities around the�world while building, acquiring, and growing businesses and brands to become a world class�global cannabis and hemp company.

MYM is positioning itself to

become a global leader in

cannabis, hemp, and seed

cultivation. Through a variety of

global partnerships in agricultural

friendly zones, MYM will have

cultivation centres around the

globe. Our ability to cultivate

indoor, outdoor and greenhouse

cannabis and hemp will be

transferrable to other projects

around the world.

MYM ‘s cultivation projects

include extraction capabilities

and expertise. The ability to

extract the biomass that is

cultivated on-site will provide

MYM with an economic

advantage, lowering the costs of

producing extracts and in turn

providing substantially higher

profit-margins to our

shareholders.

By creating strategic geographic

partnerships around the world,

MYM is in a prime position to take

advantage of economical

distribution channels. Having

interests in every corner of the

globe will make the distribution of

cannabis products a viable option

for every region.

MYM is in the process of building

a number of cannabis brands for

use in a wide variety of global

markets. Market research is being

assessed across the globe to

determine what each country’s

consumers will demand in a

cannabis brand.

Cultivation Extraction Distribution Unique Brands


Global Operations

WEEDON, CANADA

NEVADA, USACANNABIS

HEMP

MEDICAL

EXTRACTION

AUSTRALIA


MEDELLIN, COLOMBIA

LAVAL, CANADAAnnual Production at Full Capacity =

2,580 kgs

Annual Production at Full Capacity =

585,000 kgs


160,000 kgs


54,000 kgs


TBD

Small batch, super premium, indoor cannabis production facility

LAVAL, CANADACutting edge, highly optimized, indoor facility with a

planned 37,000 sf that will harvest every 21 days.

Facility includes mothering and cloning area allowing

for exceptional genetic development and archiving.

At 10,000 sf, Phase 1 is complete and awaiting

licensing from Health Canada. The Cannabis Tracking

and Licensing System has been completed and filed.

The facility plans to focus on high quality specialty

“craft” cannabis varieties.

CULTIVATION LICENSE FOR PHASEONE IS EXPECTED IN Q2 2019

CROPS FOR VALIDATION WITHHEALTH CANADA IN Q3 2019

SALE OF SEEDS AS ADDITIONALREVENUE STREAM

TOTAL ANNUAL PRODUCTION ATFULL CAPACITY = 2,580 KGS

3000 acres of USDA compliant cultivation land located on the Navajo Nation

WEEDON, CANADAThe 1.5 million sf greenhouse project has been

approved by the City of Weedon. A license

application has been submitted to Health Canada.

Once approved, the Weedon project has the

potential to be one of the largest cannabis

production facilities in Canada.

SUBMIT EVIDENCE PACKAGEFOR HEALTH CANADA BY Q4 2019

MYM HAS PURCHASED 329 ACRESTO BUILD THE PROJECT

INITIAL BUILD OUT OF 30,000 SQ FTGREENHOUSE IS UNDERWAY


Potentially one of the largest greenhouse cultivation projects in Canada

3000 acres of USDA compliant cultivation land located on the Navajo Nation

Partnership with Elite Ventures to grow 125 acres of

CBD-rich hemp in Nevada. Elite will plant, grow, and

harvest the hemp. Based on previous crops grown on

the property, the estimated production is 54,000 kgs

per harvest with potential revenue of $26 million of

which MYM is entitled to 50%.

ESTIMATED CBD LEVELSBETWEEN 10%-19%

POTENTIAL ANNUAL REVENUEOF OVER $17,500,000

POTENTIAL TO INCREASE ACREAGEFOR 2020 GROWING SEASON


NEVADA, USA

Potentially one of the largest greenhouse cultivation projects in Canada

CBD-rich hemp production agreement with immediate revenue generating potential

Launching point for Asia Pacific operations

AUSTRALIAMYM is exploring a number of projects in Australia

with the goal of becoming one of the largest cannabis

producers in the Southern Hemisphere.

CURRENTLY NEGOTIATING DEALS INEXCESS OF 1000 ACRES

IN NEGOTIATIONS WITH MULTIGENERATIONAL FARMERS IN THE REGION

ESTIMATED FIRST CULTIVATIONIN EARLY 2020

TOTAL PRODUCTION = TBD

MYM has acquired 80% of Colombia Organica , a

Colombian company that holds 3 licenses: production

of THC cannabis derivatives, cultivation of

psychoactive cannabis, and cultivation of

non-psychoactive cannabis, including exportation.

Colombia Organica has selected for production high

quality plants which are suited to the unique high

altitude, equatorial regions of Colombia.

LICENSES WILL BE EXTENDED TO OTHERPROPERTIES WITHIN THE COUNTRY

PROJECT UNDERWAY TO BUILD APRODUCTION FACILITY NEAR MEDELLIN

APPLICATION SUBMITTED TO REGISTER102 CANNABIS STRAINS


MEDELLIN, COLOMBIA

Launching point to South American operations with initial 34 acre outdoor and greenhouse grow


Yield

Kilograms of Cannabis& Hemp Per Year

800,000Size

Acres of ProductionLand

205

Production Totals

Senior Management

Howard SteinbergExecutive Vice Chairman of

the Board and CEOErick Factor

Executive Chairman, Founder

Elizabeth Liu, QCExecutive Vice-President and Chief Legal Officer

Ms. Liu will provide the company with a broad range of strategic and

risk management advice. Ms. Liu has acted for both early stage and

established companies and has served as the chief operating officer

for a number of them including some in the natural health products

industry. Ms. Liu was appointed Queen’s Counsel in 2016.

Robin Linden contributes over 20 years of leadership and management

experience, including roles in the adult beverage, luxury retail, and

luxury hotel industries.

Mark Forster has 30 years of experience in financial and

management accounting in banking, manufacturing, oil and gas, and mining

companies. His prior CFO experience includes Oracle Energy Corps and

Teletouch Services Inc.

Charith Adkar completed his PhD in Plant Biology and Crop Production from the University of Milano, Italy with the specialization in Molecular

Plant Pathology. He has done his postdoctoral studies at Hirosaki

University, Japan and Université de Sherbrooke, Canada.

A Harvard Business School alumnus, Mr. Cheetham has extensive

experience leading teams across the finance, marketing and

communications, and technology industries.

Mr. Erick Factor has been appointed to the Company’s Board of Directors and will also serve as Executive Chairman.

Mr. Factor is a well-known expert in the cannabis industry and has 20 years of experience in cultivating

medical marijuana and manufacturing.

Mr. Steinberg has more than 20 years investment experience as a senior

executive, working within some of the largest financial institutions in the world.

He has sat on over a dozen Boards including his current role as Executive

Chairman of Parallax Developments Corp and as a board member of

Trichome Financial.

Robin LindenExecutive Vice President

and Chief Marketing Officer

Mark ForsterChief Financial Officer

Charith AdkarChief Science Officer

Paul CheethamChief Operating Officer

Facilities & Territories

Fabian SzatmaryASIA PACIFIC

Territory Manager

Daniel AlonsoGabriel Ramirez

SOUTHAMERICA

Territory Managers

James AndrewsUSA

Territory Manager

Fabian GarciaZach Tietolman

CANADA

Territory Managers

CSE:MYMOTC:MYMMF

125,700,000

Capital Structure

Shares Issued& Outstanding

10,100,000

Total OptionsOutstanding

24,200,000Outstanding Warrants & Options

149,900,000Total Shares Fully Diluted

14,100,000

OutstandingWarrants

As of February 8, 2019

PRIVILEGED & CONFIDENTIAL

Vancouver#250 1095 W Pender St

Vancouver BCV6E 2M6

Toronto#108 250 Carlaw Ave

Toronto ONM4M 3L1

USA11 S Swinton AveDelray Beach FL

33444

[email protected]

Documents

STRATEGIC PLAN Q2 2019 - MYM · for exceptional genetic development and archiving. At 10,000 sf, Phase 1 is complete and awaiting licensing from Health Canada. The Cannabis Tracking